methamphetamine and Brain Neoplasms

methamphetamine has been researched along with Brain Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Capelôa, T; Caramelo, F; Fontes-Ribeiro, C; Gomes, C; Silva, AP	1
Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J	1
Kast, RE	2
Ellis, KL; Speed, J	1

Reviews

1 review(s) available for methamphetamine and Brain Neoplasms

Article	Year
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma. Journal of neuro-oncology, 2009, Volume: 94, Issue:2 Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A	2009

Article

Year

Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.

Journal of neuro-oncology, 2009, Volume: 94, Issue:2

Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A

2009

Other Studies

4 other study(ies) available for methamphetamine and Brain Neoplasms

Article	Year
Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate. Neurotoxicity research, 2014, Volume: 26, Issue:3 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Chemotaxis; Doxorubicin; Glioblastoma; Humans; Methamphetamine; Methotrexate	2014
Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line. Neurochemical research, 2015, Volume: 40, Issue:7 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Glioma; Melatonin; Methamphetamine; NF-E2-Related Factor 2; NF-kappa B; Rats; Up-Regulation	2015
Using blood brain barrier disruption by methamphetamine for drug delivery. Journal of neuro-oncology, 2007, Volume: 85, Issue:1 Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Central Nervous System Stimulants; Drug Delivery Systems; Humans; Methamphetamine	2007
Pharmacologic management of movement disorder after midbrain haemorrhage. Brain injury, 1998, Volume: 12, Issue:7 Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders	1998